News

NCI credit

Understanding the origins of Hodgkin lymphoma cells could lead to better diagnostics

27 April 2026
Diffuse Large B Cell Lymphoma model - Credit Kristie Bariboloka / image visualised and analysed using QuPath

Discovery of a novel vulnerability in aggressive lymphoma could change future therapy

27 April 2026
Imaging mass cytometry (IMC) staining of a human PDAC section, using metal-conjugated antibodies to mark different cell types, and apCAF markers. The arrows point to examples of apCAFs in the PDAC stroma.

New scoring tool shows radiation can reprogram pancreatic tumour environment

27 April 2026
heart

The beating of the heart suppresses growth in cardiac cancers

27 April 2026
chronic myeloid leukaemia

FLAG-based regimen delivers strong outcomes in subtype of acute myeloid leukaemia

27 April 2026
antibody

New targeted therapy shows promise against aggressive childhood and adult cancers

27 April 2026
generic

AACR 2026: Researchers define a mechanism‑driven strategy for targeting p53‑mutant cancers

24 April 2026
Immunofluorescence image showing GPX4 (red cells), NRAS (green cells) and NRAS/GPX4 (yellow cells) in mouse. - Credit Mariantonietta D’Ambrosio, MRC Laboratory of Medical Sciences

Exploiting a new vulnerability that targets 'zombie’ cells as an anticancer therapy

24 April 2026
Brain, connections, AI, artificial intelligence, neurotransmitter

Researchers teach AI to spot cancer risk by squeezing individual breast cells

24 April 2026
Cancer during pregnancy, a challenge that can be overcome - 2749.jpg

Cancer during pregnancy has lasting psychological impact on the wellbeing of women

24 April 2026
DNA, chromosomes, pixabay

Extra sets of chromosomes may help aggressive tumour cells spread, study finds

24 April 2026
Children Generic

Tovorafenib approved in the EU as the first targeted therapy in relapsed or refractory paediatric low-grade glioma regardless of BRAF alteration

24 April 2026
Back to Top